Replies to post #212877 on Biotech Values

[DewDiligence]

RVNC—Agree with your main points.

...the "analysts" never questioned about when the dilution will happen. They do know on which side of the bread the butter is on lol.

Moreover, no analyst inquired about 2Q17 ATM usage, so we'll have to wait for the 10-Q filing to get the details.